International Patent: NUCLEIC ACID MOLECULE FOR INHIBITING MRNA EXPRESSION VIA RNAI, AND USE THEREOF

GENEVA, July 9 -- CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD filed a patent application (CN2025/147946) for “NUCLEIC ACID MOLECULE FOR INHIBITING MRNA EXPRESSION VIA RNAI, AND USE THEREOF”. With publication no. WO/2026/145678, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....